The Gene and Virus Therapy Program harnesses genes and viruses to infect and kill tumor cells, which will ultimately expand treatment options for patients with cancer. Contact us about our research to improve cancer outcomes by advancing development of gene and virus therapy, oncolytic virotherapy, immunomodulation, and vector development, or for information about collaborative research opportunities with the program.